-
Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced Pancreatic Cancer
06 Aug 2025 12:45 GMT
… elraglusib in combination with gemcitabine/nab-paclitaxel ( … trial in combination with FOLFIRINOX and losartan in treatment- … studies, early clinical trials and sub-group … competition from other biotechnology and pharmaceutical companies; our ability …
-
Immunotherapy-Based Trials Challenge Chemotherapy Dominance in MIBC
06 Aug 2025 05:33 GMT
… bladder cancer (MIBC) treatment paradigm, according to Waddah … trial (NCT03732677) regimen of perioperative durvalumab (Imfinzi) plus neoadjuvant gemcitabine … UT) Southwestern Medical Center; as well as medical director of … are no big trials to try to spare …
-
Starving Tumors Makes Cancer Treatment Work Better
06 Aug 2025 04:39 GMT
… for immune cells and drugs to reach the tumor,… blood vessels that can promote drug delivery," said Zhang. … effects of combining a treatment to block macropinocytosis with … as a pre-treatment before using the chemotherapy gemcitabine," said …
-
Lisata Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
07 Aug 2025 20:05 GMT
… pharmaceutical company developing innovative therapies for the treatment … Health and Medical Research Council Clinical Trial Centre … 47;2a trial of certepetide plus gemcitabine and nab- … drug candidates, the timing for starting and completing clinical trials …
-
UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results
07 Aug 2025 12:00 GMT
… (Nasdaq: URGN), a biotech company dedicated to developing and … first and only FDA-approved medication for adults with … 3 UTOPIA clinical trial of investigational drug UGN-103 (mitomycin … UGN-201 or gemcitabine. The treatments demonstrated an acceptable …
-
HUTCHMED Reports 2025 Interim Results
07 Aug 2025 11:00 GMT
… ®, nab-paclitaxel and gemcitabine in late 2025 ( … drug resistance to existing treatment.
Improved safety and prolonged treatment … in the Healthcare, Pharmaceutical, and Biotechnology sector. FINANCIAL … ) Act 2018). Medical Information This announcement contains …
-
RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire
06 Aug 2025 12:30 GMT
… for patients undergoing treatment. Importantly, TAMP … Drug Administration (FDA)-cleared local drug-delivery device, targeting high unmet medical … with gemcitabine received Orphan Drug Designation for … trial and any other preclinical studies, clinical trials …
-
Reducing Clinical Resource Burden: Impact of Less Frequent NMIBC Therapy Administration
04 Aug 2025 15:39 GMT
… resource burden compared with combination treatments like gemcitabine-docetaxel, which require extensive …
-
How to bill for mitomycin for intravesical solution in NMIBC
04 Aug 2025 13:48 GMT
… UGN-102), which the FDA approved in June 2025. … and usually require aggressive treatment such as cystectomy or … BCG, mitomycin, docetaxel, and gemcitabine, among others.
Upon diagnosis, … by Medicare, carriers are instructed to reimburse the drug at …
-
Regulatory tracker: Teva's Ajovy picks up pediatric label expansion
02 Jul 2025 21:48 GMT
… two phase 3 trials in which the Blenrep … alongside the chemotherapy drugs gemcitabine and cisplatin for initial treatment of adults … potentially update the medicine’s label.
The FDA has granted priority … in Europe, Vertex Pharmaceuticals is continuing to grow its …